9p21 DNA variants associated with coronary artery disease impair interferon-γ signalling response.
Hits:
DOI number:10.1038/nature09753
Journal:Nature
Abstract:Genome-wide association studies have identified single nucleotide polymorphisms (SNPs) in the 9p21 gene desert associated with coronary artery disease (CAD) and type 2 diabetes. Despite evidence for a role of the associated interval in neighbouring gene regulation, the biological underpinnings of these genetic associations with CAD or type 2 diabetes have not yet been explained. Here we identify 33 enhancers in 9p21; the interval is the second densest gene desert for predicted enhancers and six times denser than the whole genome (P < 6.55 × 10(-33)). The CAD risk alleles of SNPs rs10811656 and rs10757278 are located in one of these enhancers and disrupt a binding site for STAT1. Lymphoblastoid cell lines homozygous for the CAD risk haplotype show no binding of STAT1, and in lymphoblastoid cell lines homozygous for the CAD non-risk haplotype, binding of STAT1 inhibits CDKN2BAS (also known as CDKN2B-AS1) expression, which is reversed by short interfering RNA knockdown of STAT1. Using a new, open-ended approach to detect long-distance interactions, we find that in human vascular endothelial cells the enhancer interval containing the CAD locus physically interacts with the CDKN2A/B locus, the MTAP gene and an interval downstream of IFNA21. In human vascular endothelial cells, interferon-γ activation strongly affects the structure of the chromatin and the transcriptional regulation in the 9p21 locus, including STAT1-binding, long-range enhancer interactions and altered expression of neighbouring genes. Our findings establish a link between CAD genetic susceptibility and the response to inflammatory signalling in a vascular cell type and thus demonstrate the utility of genome-wide association study findings in directing studies to novel genomic loci and biological processes important for disease aetiology.
Volume:470
Issue:7333
Page Number:264-8
Translation or Not:no
-
|
OfficePhone:5c1df5c38426024ee18bea394b33a5975e635717e0dffde1dfee70e29a867a12c16f3e36c786d3fa9268b527cd40967b5a5faa808811c0192c05e703c31f449474c3c3a33ddae87b37af056c51ca73069fc9cfa15d6c6f620192c5fc29019332f713efb4f2e51f914cd2ac5fc3269928435a285336e98381a666d3ce04816a38
Email:46e7171a46419971b53a20af1b0741c5b05e8a3bab9e89e5167428c13232c9f0f67529a2d8360b7d94945cfa3750b54a60d61a8163620fa1c6424d341681e4ae3c9bf9cb0b539c612a2e098308820b3844cf79d276ab2afc0522f9c1b2778bb2a97779ed8b9e44613a0504890b0db2de53489141073b941ac6cc3b6c60bda015
|